INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1297448481-data privacy china]( "Data Privacy And Trust In China's Clinical Trials")
Data Privacy And Trust In China's Clinical TrialsChina’s evolving privacy laws are reshaping how global trials operate. Sponsors that prioritize transparency and participant confidence can meet compliance demands while building lasting trust.
-
![GettyImages-2223908587-doctor-patient]( "Developing Community-Based And Trial-Naïve Sites: The Real ROI")
Developing Community-Based And Trial-Naïve Sites: The Real ROITrial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.
-
![medidata screenshot]( "The True Science Behind eCOA, Shaped By Patient And Site Insights")
The True Science Behind eCOA, Shaped By Patient And Site InsightsThis webinar brings together patients, sites, and eCOA science to dismantle the researcher-subject hierarchy and replace it with a collaborative model.
-
![Cell And Gene Therapy Supply Chains Precision At Every Step]( "Cell & Gene Therapy Supply Chains: Precision At Every Step")
Cell & Gene Therapy Supply Chains: Precision At Every StepCell and gene therapy supply chains leave little room for error. Discover strategies to improve coordination, reduce risk, and keep treatments on track.
-
The Hidden Healthcare Benefits That Home Trial Support Provides7/22/2025
Examine how Home Trial Support (HTS) enhances both patient and caregiver safety and well-being, while alleviating pressures on sites and generating greater ROI for sponsors.
-
Gene, Cell, And RNA Therapy Landscape Continues To Thrive3/21/2025
The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.
-
Strategies For Biomarker Development And Early Phase Clinical Studies5/2/2025
Companion diagnostics (CDx) are crucial for personalized medicine to enable precise patient selection for therapies. Explore biomarker development strategies and early-phase study considerations.
-
Rethinking Alzheimer's Trial Recruitment And Why It Can't Wait1/14/2026
Alzheimer's trials face urgent recruitment challenges. Data-driven strategies, digital tools, and community engagement can accelerate enrollment and improve retention in this complex therapeutic space.
-
Participants Don't Care How Your Vendor Stack Works6/16/2026
Participants experience one study, not the vendor stack behind it. Learn how sponsors and CROs can reduce burden with support built around real study needs.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1390000434 patients]( "Revolutionizing Engagement, Education, & Enrollment Across Clinical Portfolios")
Discover ways to amplify dialogue, trust, and participation around your clinical trials with Citeline’s end-to-end enterprise patient engagement and recruitment solution.
-
![Kidneys]( "Turnkey Solutions For Your Renal And Hepatic Impairment Studies")
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
![rules, policies, regulatory documents-GettyImages-1438925546]( "Are You Preparing For First-In-Human Clinical Trials?")
Reach critical first-in-human milestones faster with experienced teams, rapid study start-up, and real-time data that reduce complexity, inform decisions, and de-risk development.
-
![GettyImages-1492337134 doctor notes]( "Clinical Operations And Project Management")
Consider the benefits of an integrated operations and project management approach across all phases and regions.
-
![GettyImages-2223908587-doctor-patient]( "Delivering Precise, Reliable Data For Your Schizophrenia Research")
Struggling with rater consistency or endpoint selection in your schizophrenia trial? Learn how deep neuroscience expertise safeguards data quality and drives faster decisions.
